Creative Medical Technology Holdings, Inc. (CELZ)
0.623
+0.02
(+2.81%)
USD |
NASDAQ |
Nov 06, 10:25
Creative Medical Technology Holdings Net Income (Quarterly) : -1.511M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.511M |
| March 31, 2026 | -1.404M |
| December 31, 2025 | -1.888M |
| September 30, 2025 | -1.236M |
| June 30, 2025 | -1.233M |
| March 31, 2025 | -1.638M |
| December 31, 2024 | -1.854M |
| September 30, 2024 | -1.040M |
| June 30, 2024 | -1.558M |
| March 31, 2024 | -1.042M |
| December 31, 2023 | -1.679M |
| September 30, 2023 | -1.454M |
| June 30, 2023 | -1.102M |
| March 31, 2023 | -1.052M |
| December 31, 2022 | -6.216M |
| September 30, 2022 | -0.9823M |
| June 30, 2022 | -1.791M |
| March 31, 2022 | -1.155M |
| December 31, 2021 | -3.876M |
| September 30, 2021 | -1.844M |
| June 30, 2021 | -2.905M |
| March 31, 2021 | 27.84M |
| December 31, 2020 | -38.62M |
| September 30, 2020 | 0.3949M |
| June 30, 2020 | -1.843M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.742M |
| December 31, 2019 | -5.192M |
| September 30, 2019 | -2.406M |
| June 30, 2019 | -0.0882M |
| March 31, 2019 | -0.7974M |
| December 31, 2018 | 1.934M |
| September 30, 2018 | -1.571M |
| June 30, 2018 | -6.432M |
| March 31, 2018 | -7.587M |
| December 31, 2017 | -1.477M |
| September 30, 2017 | -0.0522M |
| June 30, 2017 | -0.8864M |
| March 31, 2017 | -0.2434M |
| December 31, 2016 | -0.1945M |
| September 30, 2016 | -0.2145M |
| June 30, 2016 | -0.2092M |
| March 31, 2016 | -0.0051M |
| December 31, 2015 | -0.0089M |
| September 30, 2015 | -0.0063M |
| June 30, 2015 | -0.0063M |
| March 31, 2015 | -0.0093M |
| December 31, 2014 | -0.0065M |
| September 30, 2014 | -0.0058M |
| June 30, 2014 | -0.0057M |
| March 31, 2014 | -0.01M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 53.52M |
| Alnylam Pharmaceuticals, Inc. | 2.167B |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.512M |
| EPS Diluted (Quarterly) | -0.4085 |
| Enterprise Value | -4.881M |
| Earnings Yield | -285.3% |
| Normalized Earnings Yield | -285.33 |